GlaxoSmithKline (GSK) BV/share US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| BV/share, rub | -21.6 | -5.35 | -5.18 | -4.33 | -7.28 | -4.96 | |||
| Changes by years, y/y, % | +22% | -75% | -3% | -16% | +68% | -16.3% | |||
GlaxoSmithKline. BV/share, rub
GlaxoSmithKline. BV/share, changes, %
GlaxoSmithKline (GSK) BV/share US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| BV/share, rub | -5.70 | -4.94 | -5.23 | -7.34 | -4.96 | -4.96 | ||
| Changes by years, y/y, % | +4% | -1% | +39% | +70% | -13% | |||
| Changes by quarters, q/q, % | +32% | -13% | +6% | +40% | -32% | |||